Viropro Inc.
8515, Place Devonshire
Suite 207
Montreal
Quebec
H4P 2K1
Canada
Tel: 514-731-VPRO
Fax: 514-739-7000
Website: http://www.viropro.com/
Email: info@viropro.com
37 articles about Viropro Inc.
-
Letter Of Intent To Acquire NovaRx Corporation Expires; Viropro Inc. Appoints New Slate Of Officers
5/2/2016
-
Pharmaceutical And Biotechnology Patent Expert John Doll Joins Viropro Inc. Board
2/16/2016
-
Dr. Ivor Royston, Oncologist, Entrepreneur, Investor And A Founder Of San Diego Biotech, Joins Viropro Inc. Board
12/8/2015
-
Viropro Inc. Announces Signing Of Letter Of Intent To Acquire Viropro Inc.
10/23/2015
-
Plagued By Multiple Facility Break-ins and Bad Management Decisions, Viropro Inc. Implements Restructuring Plan
2/3/2015
-
Viropro Inc. Subsidiary Alpha Biologics Sdn Bhd (ABSB)'s Assets Have Been Seized By A Bank In Malaysia
9/23/2014
-
Viropro Inc. Initiates Interim Debt Financing Of Up To $500,000
8/26/2014
-
Viropro Inc. and Oncobiologics Inc. Sign Emerging Markets Biosimilars Deal
2/25/2013
-
Viropro Inc. to Unlock Value from its Biosimilars Portfolio; Creates a Biosimilars Technology Subsidiary in Canada
5/16/2012
-
Viropro Inc. Appoints Michelle Peake to Chief Executive Officer of Alpha Biologics Sdn Bhd (ABSB) Subsidiary Based in Penang, Malaysia
10/3/2011
-
Viropro Inc. Retains Cooper Global Communications as Investor Relations Advisor
8/12/2011
-
Viropro Inc.'s Dr. Rajiv Datar to be Guest Speaker at SALSS
8/2/2011
-
Viropro Inc. Provides Company Updates
8/1/2011
-
Viropro Inc. Postpones Stockholders Meeting
7/27/2011
-
Viropro Inc. Update on the Business Plan
3/17/2011
-
Viropro Inc. Acquires A Major Biotech GMP Production Facility
2/22/2011
-
Viropro Inc. Signs a Binding Letter of Agreement For a Multi Million Development Contract With NASDAQ Listed Spectrum Pharmaceuticals, Inc.
1/5/2011
-
Viropro Inc.: New Controlling Shareholder And Appointment Of Rajiv Datar
6/2/2009
-
Viropro Inc. Reports on Its Extraordinary Special Meeting of Stockholders
1/25/2008
-
Viropro Inc. Announces Update On Financing US$1.5 Million and Announcement of an Extraordinary Special Shareholders Meeting
12/21/2007